Enhance Biotech Inc. Announces Asset Sale Agreement With Mount Cook Biosciences For Delta Receptor Portfolio
5/22/2006 11:17:58 AM
More...
|
Enhance Biotech Inc. Announces Closing Of Merger With Ardent Pharmaceuticals
10/19/2005 5:12:31 PM
More...
|
Enhance Biotech Inc.'s New Merger Partner Ardent Pharmaceuticals Announces License Agreement With ALZA Corporation (JNJ) For Pain Compound
10/19/2005 5:12:03 PM
More...
|
Enhance Biotech Inc. Announces Recruitment Of Patients For Dose Ranging Study Prior To Commencement Of Phase III Trial For Premature Ejaculation Compound LI301
10/19/2005 5:11:44 PM
More...
|
Enhance Biotech Inc. Achieves Milestones To Complete $4 Million Funding Arrangement
10/19/2005 5:11:27 PM
More...
|
Enhance Biotech Inc. Announces Further Progress With LI 316 Fertility Enhancement Products As They Move Towards Trials In Animal Fertility
10/19/2005 5:11:22 PM
More...
|
Enhance Biotech Inc. Discovers Unique Mechanism Of Action For Cellulite Treatment In Preparation For Regulatory Submission
10/19/2005 5:11:21 PM
More...
|
Enhance Biotech Inc. Appoints Internationally Acclaimed Pre-clinical Expert And Entrepreneur David Scales LLM, Ph.D., FIBiol, FRCPath To Its Board Of Directors
10/19/2005 5:11:14 PM
More...
|
Enhance Biotech Inc. To Merge With Privately-Held Ardent Pharmaceuticals
10/19/2005 5:11:00 PM
More...
|
Enhance Biotech Inc. Announces Consulting Agreement With SoleRx LLC To Accelerate Development Of Dermatology Drugs
10/19/2005 5:10:56 PM
More...
|
|